Lund, April 15th, 2024 — Emmace Consulting AB, a leading player in the pharmaceutical and medical device sectors, is pleased to announce strategic leadership transitions aimed at strengthening the competitive edge and fueling continued growth.

Dr. Anna Holmberg Appointed as New CEO

Dr. Anna Holmberg, who has served as Chair of the Board at Emmace for over a decade, will take on the position as CEO. Dr. Holmberg brings an impressive expertise in pharmaceutical and medical device development. Her previous roles include serving as CEO of a Contract Research Organization (CRO) developing pharmaceutical products and CEO of a medical device company having its own products on the market. Most recently, Dr. Holmberg has worked as a MedTech Advisor through her independent consulting firm.

Reflecting on her new role, Dr. Holmberg stated, “Having closely followed Emmace’s journey through my board membership, I believe this transition is the right move for Emmace. It will strengthen the company and our ability to deliver valuable services to our customers.”

Dr. Mårten Svensson Assumes Role as Head of Business Development

Dr. Mårten Svensson, the current CEO and founder of Emmace, will transition to the role of Head of Business Development. In addition to driving business growth, Dr. Svensson will actively contribute to the company’s innovation and technology development—an area close to his heart.

Outgoing CEO Mårten Svensson commented, “With this expansion of leadership capacity, we are well-positioned to continue Emmace’s remarkable growth trajectory.”

He added, “To our 100+ clients, rest assured that it’s business as usual. Existing commitments and contracts remain unchanged.”
Emmace looks forward to this exciting chapter and remains committed to delivering exceptional value to its clients and partners.

The change is implemented on May 1st.

For inquiries, please contact:
Mårten Svensson, marten@emmace.se,
+46 709 59 45 53, Scheelevägen 22, 223 63 Lund, Sweden